Ellington Management Group’s Integra LifeSciences IART Stock Holding History

Ellington Management Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-13,600	Closed	-$608K	–	218
2020 Q1	$608K	Buy	+13,600	New	+$714K	0.14%	207
2018 Q2	–	Sell	-10,700	Closed	-$592K	–	648
2018 Q1	$592K	Buy	+10,700	New	+$561K	0.04%	362
2016 Q4	–	Sell	-19,200	Closed	-$792K	–	659
2016 Q3	$792K	Buy	+19,200	New	+$804K	0.22%	120

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Ellington Management Group's IART Position: Q2 2020 in Review

Ellington Management Group sold out of Integra LifeSciences (IART) in Q2 2020, closing a stake of 13,600 shares — an estimated $608K sold.

Ellington Management Group first reported a position in IART in Q3 2016 and held it in 3 quarters. The position peaked at $792K in Q3 2016. 264 funds tracked by Wall St. Rank hold IART as of Q2 2020.

Ellington Management Group reported no remaining Integra LifeSciences position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 13,600 Integra LifeSciences shares in Q2 2020, an estimated $608K.
Ellington Management Group first reported a position in Integra LifeSciences in Q3 2016 and held it in 3 quarters.
Ellington Management Group's Integra LifeSciences position peaked at $792K in Q3 2016.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.